MedPath

Ozagrel

Generic Name
Ozagrel
Drug Type
Small Molecule
Chemical Formula
C13H12N2O2
CAS Number
82571-53-7
Unique Ingredient Identifier
L256JB984D

Overview

Ozagrel has been used in trials studying the treatment of Dry Eye Syndromes.

Indication

用于缺血性脑卒中急性期,蛛网膜下腔出血手术后的脑血管痉挛收缩和伴随的脑缺血症状。

Associated Conditions

No associated conditions information available.

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Ozagrel Sodium and Sodium Chloride Injection
国药准字H20030449
化学药品
注射剂
12/6/2019
Ozagrel Sodium and Sodium Chloride Injection
国药准字H20030102
化学药品
注射剂
2/20/2021
Ozagrel Sodium and Sodium Chloride Injection
国药准字H20052059
化学药品
注射剂
7/23/2020
Ozagrel Sodium and Sodium Chloride Injection
国药准字H20030467
化学药品
注射剂
7/23/2020
Ozagrel Sodium and Sodium Chloride Injection
国药准字H20051595
化学药品
注射剂
2/20/2021
Ozagrel Sodium and Sodium Chloride Injection
国药准字H20052521
化学药品
注射剂
6/30/2020
Ozagrel Sodium and Sodium Chloride Injection
国药准字H20040331
化学药品
注射剂
6/30/2020
Ozagrel Sodium and Sodium Chloride Injection
国药准字H20040186
化学药品
注射剂
4/27/2020
Ozagrel Sodium Injection
国药准字H20093201
化学药品
注射剂
1/15/2024
Ozagrel Sodium Injection
国药准字H20040608
化学药品
注射剂
6/10/2020

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.